Seer Inc (SEER)

Currency in USD
2.080
-0.020(-0.95%)
Closed·
2.100+0.020(+0.96%)
·
SEER is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0802.130
52 wk Range
1.5502.410
Key Statistics
Prev. Close
2.1
Open
2.1
Day's Range
2.08-2.13
52 wk Range
1.55-2.41
Volume
126.39K
Average Volume (3m)
1.09M
1-Year Change
0.4831%
Book Value / Share
4.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SEER Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.000
Upside
+92.31%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Seer Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.000
(+92.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy4.00+92.31%-MaintainJul 06, 2026
Canaccord
Buy4.00+92.31%-MaintainMay 14, 2026
Canaccord
Buy4.00+92.31%-New CoverageMay 04, 2026

Seer Inc Earnings Call Summary for Q2/2026

  • Seer reported Q2 2026 revenue of $3.1M, missing estimates by 22.5%, with EPS of -$0.31 versus -$0.22 forecast; shares fell 2.78% after hours.
  • Gross margin improved to 49% from 36% in Q1, driven by better product-service mix, while operating expenses declined 19% year-over-year to $18.3M.
  • Company reaffirmed full-year 2026 revenue guidance of $16M-$18M, representing ~3% growth, expecting stronger second-half performance.
  • Management cited $209.5M cash position as sufficient to reach breakeven, despite continued losses and weak academic/government funding pressures.
  • CEO emphasized Proteograph platform validation through studies and new CCO appointment, noting 'technological advancement precedes commercial inflection.'
Last Updated: 08/12/2026, 05:18 AM
Read Full Transcript

Earnings

Latest Release
Aug 11, 2026
EPS / Forecast
-0.31 / -0.22
Revenue / Forecast
3.1M / 4M
EPS Revisions
Last 90 days

SEER Income Statement

Compare SEER to Peers and Sector

Metrics to compare
SEER
Peers
Sector
Relationship
P/E Ratio
−1.7x−7.6x−0.4x
PEG Ratio
−0.140.000.00
Price/Book
0.5x6.3x2.6x
Price / LTM Sales
8.1x2.9x3.1x
Upside (Analyst Target)
92.3%18.6%48.3%
Fair Value Upside
Unlock8.5%6.2%Unlock

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Employees
124

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.62M10.23%11.70M
Other Institutional Investors
30.22M54.97%62.86M
Public Companies & Retail Investors
19.14M34.80%39.80M
Total
54.98M100.00%114.36M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SoftBank Group Corp.9.34%5,135,38310,682
aMoon Ventures Y.SH. Ltd8.95%4,923,19610,240

People Also Watch

81.640
AXTI
+5.41%
43.54
VIAV
+1.28%
13.580
RDW
+2.88%
58.79
CTSH
-0.84%

FAQ

What Is the Seer (SEER) Stock Price Today?

The Seer stock price today is 2.080 USD.

What Stock Exchange Does Seer Trade On?

Seer is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Seer?

The stock symbol for Seer is "SEER."

What Is the Seer Market Cap?

As of today, Seer market cap is 115.170M USD.

What Is Seer's Earnings Per Share (TTM)?

The Seer EPS (TTM) is -1.220.

When Is the Next Seer Earnings Date?

Seer will release its next earnings report on Nov 10, 2026.

From a Technical Analysis Perspective, Is SEER a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Seer Stock Split?

Seer has split 0 times.

How Many Employees Does Seer Have?

Seer has 124 employees.

What is the current trading status of Seer (SEER)?

As of Aug 17, 2026, Seer (SEER) is trading at a price of 2.080 USD, with a previous close of 2.100 USD. The stock has fluctuated within a day range of 2.080 USD to 2.130 USD, while its 52-week range spans from 1.550 USD to 2.410 USD.

What Is Seer (SEER) Price Target According to Analysts?

The average 12-month price target for Seer is 4.000 USD, with a high estimate of 4 USD and a low estimate of 4 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +92.31% Upside potential.

What Is the SEER Premarket Price?

SEER's last pre-market stock price is 2.110 USD. The pre-market share volume is 1,630.000, and the stock has decreased by 0.010, or 0.480%.

What Is the SEER After Hours Price?

SEER's last after hours stock price is 2.100 USD, the stock has decreased by 0.020, or 0.960%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.